Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 32, 2002 - Issue 4
37
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse

, , , , &
Pages 339-347 | Published online: 22 Sep 2008

References

  • ANNICH, G. M., MEINHARDT, J. P., MOWERY, K. A., ASHTON, B. A., MERZ, S. I., HIRSCHL, R. B., MEYERHOFF, M. E. and BARTLETT, R. H., 2000, Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Critical Care Medicine, 28, 915–920.
  • CHEN, C., HANSON, S. R., KEEFER, L. K., SAAVEDRA, J. E., DAVIES, K. M., HUTSELL, T. C., HUGHES, J. D., Ku, D. N. and LUMSDEN, A. B., 1997, Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery. Journal of Surgical Research, 67, 26–32.
  • ESPADAS-TORRE, C., OKLEJAS, V., MOWERY, K. and MEYERHOFF, M. E., 1997, Thromboresistant chemical sensors using combined nitric oxide release/ion sensing polymeric films. Journal of the American Chemical Society, 119, 2321–2322.
  • FEELISCH, M. and STAMLER, J. S., 1996, Donors of nitrogen oxides. In M. Feelisch and J. S. Stamler (eds), Methods in Nitric Oxide Research (New York: Wiley), pp. 71–115.
  • HANSON, S. R., HUTSELL, T. C., KEEFER, L. K., MOORADIAN, D. L. and SMITH, D. J., 1995, Nitric oxide donors: a continuing opportunity in drug design. Advances in Pharmacology, 34, 383-398. KEEFER, L. K., 2000, Design of nitric oxide-releasing drugs. Pharmaceutical News, 7, 27–32.
  • KEEFER, L. K., Nims, R. W., DAVIES, K. M. and WINK, D. A., 1996, `NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods in Enzymology, 268, 281–293.
  • GILLETTE, J. R. and PANG, K. S., 1977, Theoretic aspects of pharmacokinetic drug interactions. Clinical Pharmacology and Therapeutics, 22, 623–639.
  • LEHMANN, J., 2000, Nitric oxide donors — current trends in therapeutic applications. Expert Opinion on Therapeutic Patents, 10, 579–594.
  • LIU, J., SAAVEDRA, J. E., Lu, T., SONG, J.-G., WAALKES, M. P. and KEEFER, L. K., 2002, The liver-selective nitric oxide donor, V-PYRRO/NO, protects against d-galactosamine/endotoxin-induced hepatotoxicity in mice. Journal of Pharmacology and Experimental Therapeutics, 300, 1–8.
  • LUKAS, G., BRINDLE, S. D. and GREENGARD, P., 1971, The route of absorption of intraperitoneally administered compounds. Journal of Pharmacology and Experimental Therapeutics, 178, 562–566.
  • MARAGOS, C. M., MORLEY, D., WINK, D. A., DUNAMS, T. M., SAAVEDRA, J. E., HOFFMAN, A., Bow, A. A., ISAAC, L., HRABIE, J. A. and KEEFER, L. K., 1991, Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. Journal of Medicinal Chemistry, 34, 3242–3247.
  • MOWERY, K. A., SCHOENSCH, M. H., SAAVEDRA, J. E., KEEFER, L. K. and MEYERHOFF, M. E., 2000, Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials, 21, 9–21.
  • NICKERSON, D. F. and TOLER, S. M., 1997, Intraperitoneal and intraportal administration of droloxifene to the Sprague—Dawley rat: assessing the first-pass effect. Xenobiotica, 27, 627–632.
  • NOTARI, R. E., 1987, Biopharmaceutics and Clinical Pharmacokinetics (New York: Marcel Dekker).
  • Ou, J., CARLOS, T. M., WATKINS, S. C., SAAVEDRA, J. E., KEEFER, L. K., KIM, Y.-M., HARBRECHT, B. G. and BILLIAR, T. R., 1997, Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICANI-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide: Biology and Chemistry, 1, 404–416.
  • PANG, K. S. and GILLETTE, J. R., 1978, Complications in the estimation of hepatic blood flow in vivo by pharmacokinetic parameters. The area under the curve after the concomitant intravenous and intraperitoneal (or intraportal) administration of acetaminophen in the rat. Drug Metabolism and Disposition, 6, 566–576.
  • PLUTA, R. M., OLDFIELD, E. H. and BOOCK, R. J., 1997, Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery, 87, 746–751.
  • RICCIARDI, R., FOLEY, D. P., QUARFORDT, S. H., SAAVEDRA, J. E., KEEFER, L. K., WHEELER, S. M., DONOHUE, S. E., CALLERY, M. P. and MEYERS, W. C., 2001, V-PYRRO/NO: an hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion. Transplantation, 71, 193–198.
  • SAAVEDRA, J. E., BILLIAR, T. R., WILLIAMS, D. L., KIM, Y.-M., WATKINS, S. C. and KEEFER, L. K., 1997, Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-a-induced apoptosis and toxicity in the liver. Journal of Medicinal Chemistry, 40, 1947–1954.
  • SAAVEDRA, J. E., SOUTHAN, G. J., DAVIES, K. M., LUNDELL, A., MARKOU, C., HANSON, S. R., ADRIE, C., HURFORD, W. E., ZAPOL, W. M. and KEEFER, L. K., 1996, Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. Journal of Medicinal Chemistry, 39, 4361–4365.
  • SHARGEL, L. and Yu, A. B. C. 1985, Applied Biopharmaceutics and Pharmacokinetics (Norwalk: Appleton-Century-Crofts).
  • SMITH, D. J., CHAKRAVARTHY, D., PULFER, S., SIMMONS, M. L., HRABIE, J. A., CITRO, M. L., SAAVEDRA, J. E., DAVIES, K. M., HUTSELL, T. C., MOORADIAN, D. L., HANSON, S. R. and KEEFER, L. K., 1996, Nitric oxide-releasing polymers containing the [N(0)NO] group. Journal of Medicinal Chemistry, 39, 1148–1156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.